DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
FDA. DUPIXENT® (dupilumab) injection, for subcutaneous use Initial U.S.
Approval: 2017. 2017 21.04.2022]; Available from:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761055lbl.pdf
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.